This federal contract award, valued at $1,379.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fluticasone-salmeterol 230-21, a pharmaceutical product, with a completion date of December 16, 2024.
The contract is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
The contract award does not have a set-aside designation, indicating open competition. As a major supplier to federal healthcare programs, particularly within military and veterans' healthcare systems, Amerisourcebergen's contract awards demonstrate its extensive capabilities in distributing a wide array of medical commodities, including specialty medications, generic drugs, brand-name pharmaceuticals, medical devices, and other medical supplies.
Generated 3/16/25, 12:48 AM